Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abcellera Biologics Inc 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 CAN

www.abcellera.com P: 604-559-9005

Description:

AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 820,411
Enterprise Value, $K 662,091
Shares Outstanding, K 294,054
Annual Sales, $ 38,030 K
Annual Net Income, $ -146,400 K
Last Quarter Sales, $ 9,950 K
Last Quarter Net Income, $ -40,610 K
EBIT, $ -203,510 K
EBITDA, $ -172,620 K
60-Month Beta 0.45
% of Insider Shareholders 32.45%
% of Institutional Shareholders 61.42%
Float, K 198,633
% Float 67.55%
Short Volume Ratio 0.39

Growth:

1-Year Return -62.52%
3-Year Return -86.38%
5-Year Return 0.00%
5-Year Revenue Growth 330.69%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 05/07/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -0.52
EPS Growth vs. Prev Qtr 17.65%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ABCL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -12.61%
Return-on-Assets % -9.79%
Profit Margin % -384.96%
Debt/Equity 0.00
Price/Sales 22.43
Price/Cash Flow N/A
Price/Book 0.76
Book Value/Share 3.84
Interest Coverage -1.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar